574 Results (Page 23 of 23)
Brazil Markets Research Reports
Brazil Brain Cancer Therapeutics Market Analysis
Brazil Brain Cancer Therapeutics Market valued at $58 Mn in 2022, projected to reach $138 Mn by 2030 with a 11.6% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. Among the prominent players in the pharmaceutical sector are Pfizer, AstraZeneca, Merck & Co., Siemens, Carestream Health, Eisai Co., Genentech, Bristol-Myers Squibb, Eli Lilly, and Sanofi.
Brazil Brugada Syndrome Market Analysis
The Brazil Brugada Syndrome Market was valued at $30 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $54.1 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the Brazil Brugada Syndrome Market are Eurofarma, EMS Pharma, Sanofi, Novo Nordisk, and Novartis, among others.
Brazil Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Brazil Clinical Nutrition for Chronic Kidney Diseases Market was valued at $39.20 Mn in 2023 and is predicted to grow at a CAGR of 7.03% from 2023 to 2030, to $63.10 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Brazil Adult Malignant Glioma Therapeutics Market Analysis
The Brazil Adult Glioma Therapeutics Market is valued at around $55 Mn in 2022 and is projected to reach $117 Mn by 2030, exhibiting a CAGR of 9.9% during the forecast period. The market's growth is being driven by the advent of innovative targeted therapies as well as increased awareness, both of which are addressing the growing prevalence of glioma, which is aided by improved diagnostic instruments and early detection procedures. Key players in the Brazil Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Novartis, Pfizer, AbbVie, Oncoclínica, Cmed, EMS, DASA. Etc.
Brazil Blood Disorder Therapeutics Market
Brazil Blood Disorder Therapeutics Market valued at $335 Mn in 2022, projected to reach $643 Mn by 2030 with a 8.5% CAGR. Rising prevalence of blood diseases, advanced therapies, and increased healthcare investment are driving the growth of the Brazil Blood Disorder Therapeutics Market. The Brazil market encompasses various players across different segments, including Pfizer, Sanofi, Novartis, Takeda Pharmaceuticals, CSL Behring, Alexion, Eurofarma, Hypera Pharma, Neo Quimica, Cristalia etc, among various others.
Brazil Dental Endodontics Market Analysis
Brazil Dental Endodontics Market was valued at $43.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $62.80 Mn by 2030. The key drivers of this industry include growing demand for cosmetic dentistry, Technological Advancements, rising prevalence of dental problems, and the ageing population. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others
Brazil Clinical Nutrition Market Analysis
The Brazil Clinical Nutrition Market was valued at $766.8 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $1179 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Oceandrop, Vitafor, Prodiet Medical Nutrition, Abbott Nutrition, Pfizer Inc, Nestle, Mead Johnson & Company, LLC among others.
Brazil Breast Pump Market Report
The Brazil Breast Pump Market was valued at $73.5 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $139.6 Mn by 2030. The key drivers of the market include improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players in the Brazil Breast Pump Market are Ardo, CA-MI, Lansinoh, Microlife, Nubeca, and Nuby, among others.
Brazil Digital Biomarkers Market Analysis
Brazil Digital Biomarkers Market was valued at $72.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $314.11 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Brazil Congestive Heart Failure Therapeutics Market Analysis
The Brazil Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $258 Mn in 2022 to $436 Mn by 2030, with a CAGR of 6.8% during the forecast period of 2022-2030. An expanding patient base due to rising cardiac disease prevalence, increased healthcare access around the country, and a thriving R&D environment are the key factors driving the market growth in Brazil. The Brazil Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Hypera Pharma, Ache Laboratories, EMS Pharma, Neo Quimica, Teuto Brasileiro, etc, among various others.
Brazil Cancer Induced Bone Disease Therapeutics Market
Brazil Cancer Induced Bone Disease Therapeutics Market valued at $33 Mn in 2022, projected to reach $55 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the rising incidence of cancer, improved diagnostics and treatment, and the potential for local manufacturing. The industry is primarily dominated by players such as Advaxis, CancerVax, Pfizer, Takeda, Gradalis, Hikma, and Zentalis among others.
Brazil Medication Access Programs Market Analysis
The Brazil Medication Access Programs Market was valued at $137.2 Mn in 2023 and is predicted to grow at a CAGR of 15.6% from 2023 to 2030, to $378.6 Mn by 2030. The key drivers of this industry include the high prevalence of chronic disease, the large uninsured population, and government initiatives. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
Brazil Dental Consumables Market Analysis
The Brazil Dental Consumables Market was valued at $845 Mn in 2023 and is projected to grow at a CAGR of 9.0% from 2023 to 2023, to $1544.7 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Institut Straumann AG, Coltene, EDLO ITM, ZimVie Inc, SIN Implant System among others.
Brazil Physiotherapy Equipment Market Analysis
The Brazil Physiotherapy Equipment Market was valued at $522.50 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $907.15 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Cremer, BTL Industries, EMS Emefarma, and Enraf-Nonius BV among others
Brazil Patient Adherence Programs Market Analysis
The Brazil Patient Adherence Programs Market was valued at $323.9 Mn in 2023 and is predicted to grow at a CAGR of 19.0% from 2023 to 2030, to $1094.6 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Brazil Patient Adherence Programs Market are Amil, Bradesco Saude, Novartis, Sanofi, and Pfizer, among others.
Brazil Cardiac Resynchronization Therapy Market
Brazil Cardiac Resynchronization Therapy Market valued at $120 Mn in 2022, projected to reach $191 Mn by 2030 with a 6% CAGR. The global rise in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a key factor contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, leading participants in this market include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.
Brazil Cardiac Arrhythmia Therapeutics Market
Brazil Cardiac Arrhythmia Therapeutics Market valued at $180 Mn in 2022, projected to reach $305 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the rising burden of cardiac conditions, technological advancements, and growing healthcare expenditure. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, Biolab Sanus, Johnson & Johnson, and Boston Scientific among others.
Brazil Kidney Cancer Therapeutics Market Analysis
The Brazil Kidney Cancer Therapeutics Market was valued at $157.25 Mn in 2023 and is predicted to grow at a CAGR of 5.86% from 2023 to 2030, to $234.27 Mn by 2030. Brazil Kidney Cancer Therapeutics Market is growing due to an Increase in Geriatric Population, a Rise in Lifestyle disorders, and Growing Pipeline of Novel Therapies. Amgen Inc., Bayer AG, F. Hoffmann-La Roche, Bristol Myers Squibb, and Abbott Laboratories are the major companies operating in the Brazil Kidney Cancer Therapeutics Market.
Brazil LASIK Surgery Market Analysis
Brazil LASIK Surgery Market was valued at $88.25 Mn in 2023 and is predicted to grow at a CAGR of 6.21% from 2023 to 2030, to $134.55 Mn by 2030. The key drivers of this industry include rising prevalence, evolving consumer habits, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Brazil Medical Digital Imaging System Market Analysis
The Brazil Medical Digital Imaging System Market was valued at $762.50 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $1411.88 Mn by 2030. The key drivers of this industry include healthcare spending, technological advancements, and rising chronic diseases. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Brazil Hemodialysis Vascular Grafts Market Analysis
Brazil Hemodialysis Vascular Grafts Market was valued at $5.24 Bn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $7.93 Bn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, the growing geriatric population, and government investment in healthcare. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Brazil Breastfeeding Accessories Market Analysis
Brazil Breastfeeding Accessories Market was valued at $62.75 Mn in 2023 and is predicted to grow at a CAGR of 7.80% from 2023 to 2030, to $106.16 Mn by 2030. The key drivers of this industry include early disease detection, personalized medicine, and government funding. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
Brazil Hospital Market Analysis
The Brazil Hospital Market was valued at $137.49 Bn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $244.95 Bn by 2030. The key drivers of this industry are rise in the geriatric population, technological advancement, and government initiatives. The key players in the industry are Hospital São Rafael, Rede D'Or São Luiz, Hospital Alemão Oswaldo Cruz, and Hospital Samaritano among others.
Brazil Hemodialysis Equipment Market Analysis
The Brazil Hemodialysis Equipment Market was valued at $353 Mn in 2023 and is projected to grow at a CAGR of 8.6% from 2023 to 2023, to $628.9 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Dialife, Renaltech, Biomed, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic Ltd among others.
